Review Article
Management of Hepatic Encephalopathy
Table 1
Treatment stratagems used in HE.
| HE grade: I-II |
| General management |
| Hyperammonemia | Dietary protein supplementation | Purgatives | (i) Nonabsorbable disaccharides | (ii) Enemas | Non-absorbable antibiotics | Modulation of interorgan ammonia | (i) L-ornithine, L-aspartate (LOLA) | (ii) Sodium benzoate | (iii) Phenylacetate | Others | (i) Flumazenil “Bromocriptine” acarbose | Emerging therapies | (i) Probiotics |
| HE grade: III-IV |
| Cerebral edema & elevated ICP |
| General | (i) Ventilate | (ii) Sedate (e.g., Propofol) | Specific | (i) Antimicrobials | (ii) Hypertonic saline | (iii) Mannitol | (iv) Dexamethasone | (v) Induced hypothermia | (vi) Thiopentone | (vii) Indomethacin | (viii) Antiepileptic drugs (AED’S) | (ix) N-acetylcysteine (NAC) |
| Transplantation |
| Orthotopic liver transplant (OLT) | Partial hepatectomy | Liver assist devices |
|
|